Patient, Diagnosis, and Treatment Delays Among Tuberculosis Patients Before and During COVID-19 Epidemic-China, 2018-2022
Authors:
Open Access
- 22 March 2023
- Vol. 5 (12) , 259-265
Abstract
What is already known about this topic? The coronavirus disease (COVID-19) pandemic could have a damaging impact on access to tuberculosis (TB) diagnosis and treatment. What is added by this report? The overall delay experienced by TB patients during the COVID-19 pandemic has shown a modest decrease in comparison to the period before the pandemic. Notably, higher patient delays were observed among agricultural workers and those identified through passive case-finding methods. Furthermore, the patient delay in eastern regions was shorter compared to western and central regions. What are the implications for public health practice? The observed increase in patient delay in 2022 should be of concern for ongoing TB control efforts. Health education and active screening initiatives must be enhanced and broadened among high-risk populations and regions characterized by extended patient delays.Keywords
This publication has 5 references indexed in Scilit:
- Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, ChinaFrontiers in Public Health, 2021
- The impact of the COVID-19 epidemic on tuberculosis control in ChinaThe Lancet Regional Health - Western Pacific, 2020
- Total Delay Is Associated with Unfavorable Treatment Outcome among Pulmonary Tuberculosis Patients in West Gojjam Zone, Northwest Ethiopia: A Prospective Cohort StudyPLOS ONE, 2016
- Tuberculosis in Migrant Populations. A Systematic Review of the Qualitative LiteraturePLOS ONE, 2013
- Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based studyBMC Health Services Research, 2013